STRATIFICATION OF VASCULAR DISEASE RISK IN CATARACT SUBJECTS AND TREATMENT SELECTION USING BIOMARKER BASED AI CLASSIFICATION FROM AQUEOUS HUMOR

Presenting Author: Naren Shetty
Country: India
mailto:narenshetty.27@gmail.com

NovoMolDX introduces a breakthrough solution – the Biomarker Pathfinder Test supported by cutting-edge AI technology. The test was developed by a seasoned team of scientists at GROW Research Laboratory, a part of Narayana Nethralaya. It provides accurate results in less than 2 hours, while the built-in AI software generates the recommended line of treatment.

The Biomarker Pathfinder Test paves the way for greater possibilities in achieving diagnostic accuracy and affordability in eye care, which will benefit the entire society.